Milad Salimibani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Milad Salimibani has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Mohammad Haghpanahi
Mechanical Department Iran University of Science and Technology Tehran Iran
2 shared publications- Reza Eivazzadeh-Keihan
Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry Iran University of Science and Technology Tehran Iran
2 shared publications - Shadie Hatamie
College of Medicine, National Taiwan University, Taipei 10048, Taiwan
2 shared publications - Adeleh Kazemi Alamouti
Department of Ocean and Mechanical Engineering, Florida Atlantic University 1 , Boca Raton, Florida 33431
1 shared publication Agnieszka Boszczyk
Affiliation Department of Optics and Photonics, Wroclaw University of Science and Technology, Wrocław, Poland
1 shared publication- Ali Dahaghin
Department of Optics and Photonics, , Wrocław, Poland
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (4) , 54
Temperature Distribution and Control in Ultrasound-Based Therapy: An Ex Vivo Study with Bioheat Transfer Modeling
In therapeutic applications, ultrasound is widely used in physiotherapy, tissue repair, and cancer treatment. Regarding cancer treatment, as an emerging field for technology, significant research efforts have been devoted to the area of ultrasound therapy. The derived energy from beams can be deposited in tissues not only through heating but also through non-thermal mechanisms, whereby cancer cells are subject to cell death. Ultrasound-induced heating can generate localized temperature elevations within biological tissues, making it a subject of interest for thermal therapeutic applications. Nevertheless, excessive temperature elevations outside the primary exposure region may result in undesirable thermal effects within the surrounding tissue. In this study, we used continuous 3 MHz ultrasound waves at the powers of 0.4 to 1.4 W on ex vivo chicken breast tissue in a water bath to prevent fluctuations in temperature. The process was also numerically modeled with a maximum error of 0.4% from the measured data. Temperature measurements revealed a significant difference between the region of maximum acoustic pressure along the beam axis and deeper tissue locations (in some cases, above 3.5 °C). These findings indicate that temperature gradients can develop within homogeneous tissue during ultrasound exposure, emphasizing the importance of controlling acoustic power and exposure conditions. Moreover, increasing the temperature was significant during the first moments of treatment, which highlights the importance of precise controls for rate and precision in therapy. The numerical simulations also showed that increasing acoustic power elevates tissue temperature while simultaneously producing a less uniform temperature distribution. These observations may be useful for the optimization of future ultrasound-based thermal treatment strategies; however, direct clinical extrapolation requires further investigation using physiologically representative tissue models.
- 25 June 2026
- Published by MDPI AG in Biophysica
- Vol. 6 (4) , 54
Open AccessTemperature Distribution and Control in Ultrasound-Based Therapy: An Ex Vivo Study with Bioheat Transfer Modeling
In therapeutic applications, ultrasound is widely used in physiotherapy, tissue repair, and cancer treatment. Regarding cancer treatment, as an emerging field for technology, significant research efforts have been devoted to the area of ultrasound therapy. The derived energy from beams can be deposited in tissues not only through heating but also through non-thermal mechanisms, whereby cancer cells are subject to cell death. Ultrasound-induced heating can generate localized temperature elevations within biological tissues, making it a subject of interest for thermal therapeutic applications. Nevertheless, excessive temperature elevations outside the primary exposure region may result in undesirable thermal effects within the surrounding tissue. In this study, we used continuous 3 MHz ultrasound waves at the powers of 0.4 to 1.4 W on ex vivo chicken breast tissue in a water bath to prevent fluctuations in temperature. The process was also numerically modeled with a maximum error of 0.4% from the measured data. Temperature measurements revealed a significant difference between the region of maximum acoustic pressure along the beam axis and deeper tissue locations (in some cases, above 3.5 °C). These findings indicate that temperature gradients can develop within homogeneous tissue during ultrasound exposure, emphasizing the importance of controlling acoustic power and exposure conditions. Moreover, increasing the temperature was significant during the first moments of treatment, which highlights the importance of precise controls for rate and precision in therapy. The numerical simulations also showed that increasing acoustic power elevates tissue temperature while simultaneously producing a less uniform temperature distribution. These observations may be useful for the optimization of future ultrasound-based thermal treatment strategies; however, direct clinical extrapolation requires further investigation using physiologically representative tissue models.
- 4 November 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (10) , 1235-1262
Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases
Degenerative retinal diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinitis pigmentosa, cause irreversible vision loss by destroying vital retinal cells and represent major global health concerns. Traditional therapies have limited success in fully restoring vision due to the complex retinal structure and blood-retinal barriers (BRBs), though they may help alleviate symptoms or slow disease progression in some cases. Nanochemistry and peptide-based systems represent breakthrough approaches by leveraging nanoscale precision and biological specificity. This review examines the chemical design and synthesis of nanoparticles (NPs), nanoscaffolds, and peptide conjugates used in retinal neural regeneration. It also explores their biomedical applications, especially in targeted drug delivery, tissue engineering, and cellular repair. Biodegradable polymeric NPs, liposomes, and hybrid nanostructures are designed to cross barriers, release drugs in a controlled manner, and enhance biocompatibility. PEGylation improves stability and reduces immune responses in the ocular environment, while peptide functionalization enables specific cellular targeting and minimizes inflammatory reactions. Peptide-functionalized platforms, such as RGD-modified NPs and self-assembling hydrogels, provide receptor-mediated targeting and extracellular matrix (ECM) mimicry to support retinal regeneration for improved stem cell differentiation and neuroprotection. We discuss drug/gene delivery mechanisms, cellular interactions, and immune modulation, as well as neuroprotection, stem cell therapy, and diagnostic applications. Preclinical studies have demonstrated promising efficacy in animal models; however, concerns regarding scalability, long-term safety, and non-invasive delivery persist. Next-generation technologies, such as stimuli-responsive NPs, computationally designed peptides, and patient-specific delivery systems, are on the horizon to address unmet clinical needs. By marrying nanochemistry’s precision with peptides’ bioactivity, these technologies have the potential to transform retinal disease treatment, enabling the restoration of vision and an improvement in quality of life for millions of people worldwide.
- 4 November 2025
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 40 (10) , 1235-1262
Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases
Degenerative retinal diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinitis pigmentosa, cause irreversible vision loss by destroying vital retinal cells and represent major global health concerns. Traditional therapies have limited success in fully restoring vision due to the complex retinal structure and blood-retinal barriers (BRBs), though they may help alleviate symptoms or slow disease progression in some cases. Nanochemistry and peptide-based systems represent breakthrough approaches by leveraging nanoscale precision and biological specificity. This review examines the chemical design and synthesis of nanoparticles (NPs), nanoscaffolds, and peptide conjugates used in retinal neural regeneration. It also explores their biomedical applications, especially in targeted drug delivery, tissue engineering, and cellular repair. Biodegradable polymeric NPs, liposomes, and hybrid nanostructures are designed to cross barriers, release drugs in a controlled manner, and enhance biocompatibility. PEGylation improves stability and reduces immune responses in the ocular environment, while peptide functionalization enables specific cellular targeting and minimizes inflammatory reactions. Peptide-functionalized platforms, such as RGD-modified NPs and self-assembling hydrogels, provide receptor-mediated targeting and extracellular matrix (ECM) mimicry to support retinal regeneration for improved stem cell differentiation and neuroprotection. We discuss drug/gene delivery mechanisms, cellular interactions, and immune modulation, as well as neuroprotection, stem cell therapy, and diagnostic applications. Preclinical studies have demonstrated promising efficacy in animal models; however, concerns regarding scalability, long-term safety, and non-invasive delivery persist. Next-generation technologies, such as stimuli-responsive NPs, computationally designed peptides, and patient-specific delivery systems, are on the horizon to address unmet clinical needs. By marrying nanochemistry’s precision with peptides’ bioactivity, these technologies have the potential to transform retinal disease treatment, enabling the restoration of vision and an improvement in quality of life for millions of people worldwide.
- 6 April 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (6) , 103777
Development of polylactic acid microneedles for enhanced transdermal delivery of desmopressin peptides: A computational study
- 6 April 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (6) , 103777
Development of polylactic acid microneedles for enhanced transdermal delivery of desmopressin peptides: A computational study
- Open Access
- 25 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320205
Effect of intraocular pressure on crystalline lens oscillations: a computational study using porcine eye model
This study addresses a crucial knowledge gap by investigating the impact of intraocular pressure (IOP) on the wobbling characteristics of the crystalline lens in an ex vivo setting. It utilizes previous validated computational porcine eye models, which offer anatomical and physiological similarities to the human eye. These models incorporate fluid-structure interaction (FSI) to simulate the mechanical interaction between the fluids of the eye and the solid structures. Simulations were conducted under constant mechanical properties and boundary conditions, allowing for precise quantification of lens wobbling behavior with varying IOP levels. Various trends in lens displacement were observed at various IOP levels, revealing significant variations in both magnitude and duration. The results demonstrate the central role of intraocular pressure in influencing lens overshooting during rotational motion, with potential clinical implications. The observed lens displacement patterns, particularly in conditions like glaucoma, underscore the importance of considering IOP as a critical factor in understanding ocular biomechanics. Beyond immediate biomechanical relevance, the study’s findings suggest the potential use of the Purkinje imaging system as a non-invasive method for IOP estimation based on lens overshoot as an “inverse solution” strategy. This non-invasive imaging technique offers a promising alternative to traditional methods, minimizing patient discomfort and potentially enhancing measurement precision.
- 25 March 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (3) , e0320205
Open AccessEffect of intraocular pressure on crystalline lens oscillations: a computational study using porcine eye model
This study addresses a crucial knowledge gap by investigating the impact of intraocular pressure (IOP) on the wobbling characteristics of the crystalline lens in an ex vivo setting. It utilizes previous validated computational porcine eye models, which offer anatomical and physiological similarities to the human eye. These models incorporate fluid-structure interaction (FSI) to simulate the mechanical interaction between the fluids of the eye and the solid structures. Simulations were conducted under constant mechanical properties and boundary conditions, allowing for precise quantification of lens wobbling behavior with varying IOP levels. Various trends in lens displacement were observed at various IOP levels, revealing significant variations in both magnitude and duration. The results demonstrate the central role of intraocular pressure in influencing lens overshooting during rotational motion, with potential clinical implications. The observed lens displacement patterns, particularly in conditions like glaucoma, underscore the importance of considering IOP as a critical factor in understanding ocular biomechanics. Beyond immediate biomechanical relevance, the study’s findings suggest the potential use of the Purkinje imaging system as a non-invasive method for IOP estimation based on lens overshoot as an “inverse solution” strategy. This non-invasive imaging technique offers a promising alternative to traditional methods, minimizing patient discomfort and potentially enhancing measurement precision.
- 1 November 2024
- Published by American Vacuum Society in Biointerphases
- Vol. 19 (6)
Numerical study of magnetic nanoparticles injection into a brain tumor considering the effects of injection volume and location on the termination of cancerous cells
Lately, magnetic nanoparticle (MNP) hyperthermia gained much attention because of its therapeutic efficiency. It is challenging to predict all the treatment parameters during the actual therapeutic environment. Hence, the numerical approaches can be utilized to optimize various parameters of interest. In the present research, MNP hyperthermia on a cancerous tumor placed inside the human brain is investigated numerically using a realistically shaped model for the head layers and the tumor. Applying the boundary conditions, a steady-state Pennes’s bioheat transfer equation is solved using the finite element method scheme. The effects of MNP injection volume and location on tumor thermal distribution are examined and discussed in detail. The total volume of the brain tumor is 5990 mm3. Three different volumes of injection per point, namely, 0.6, 1.2, and 3 μl, as well as several injection points, are performed. It is observed that choosing a higher number of MNP injection points affects the temperature distribution in terms of uniformity. In contrast, an accurate injection volume provides lower temperatures for the treatment of cancerous tissue. Moreover, it is concluded that interfaces between the different layers of the anatomically correct brain model play a critical role in thermal therapy. Based on the obtained results, it is concluded that the optimal condition for MNP hyperthermia of a cancerous tumor with a volume of 5990 mm3 is the total injection volume of 80 μl through 20 different points all over the brain tumor considering an injection volume of 4 μl for each point.
- 1 November 2024
- Published by American Vacuum Society in Biointerphases
- Vol. 19 (6)
Numerical study of magnetic nanoparticles injection into a brain tumor considering the effects of injection volume and location on the termination of cancerous cells
Lately, magnetic nanoparticle (MNP) hyperthermia gained much attention because of its therapeutic efficiency. It is challenging to predict all the treatment parameters during the actual therapeutic environment. Hence, the numerical approaches can be utilized to optimize various parameters of interest. In the present research, MNP hyperthermia on a cancerous tumor placed inside the human brain is investigated numerically using a realistically shaped model for the head layers and the tumor. Applying the boundary conditions, a steady-state Pennes’s bioheat transfer equation is solved using the finite element method scheme. The effects of MNP injection volume and location on tumor thermal distribution are examined and discussed in detail. The total volume of the brain tumor is 5990 mm3. Three different volumes of injection per point, namely, 0.6, 1.2, and 3 μl, as well as several injection points, are performed. It is observed that choosing a higher number of MNP injection points affects the temperature distribution in terms of uniformity. In contrast, an accurate injection volume provides lower temperatures for the treatment of cancerous tissue. Moreover, it is concluded that interfaces between the different layers of the anatomically correct brain model play a critical role in thermal therapy. Based on the obtained results, it is concluded that the optimal condition for MNP hyperthermia of a cancerous tumor with a volume of 5990 mm3 is the total injection volume of 80 μl through 20 different points all over the brain tumor considering an injection volume of 4 μl for each point.
- 26 February 2020
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 31 (7) , 1544-1552
Biocompatibility and hyperthermia cancer therapy of casein‐coated iron oxide nanoparticles in mice
Magnetic nanoparticles (MNPs) can be used as heat generation source in cancer hyperthermia therapy. While iron oxide nanoparticles (NPs) are the most popular choice for magnetic hyperthermia, adding a surface enhancement can improve its performance. Furthermore, for MNPs to be used in biomedical application their cytotoxicity needs to be evaluated. In this study biocompatibility and also in vivo performance of casein‐coated MNPs were assessed. Cell viability of normal cell lines in all of tests remained above 95% for 0.5 and 1 mg/mL concentration and even the minimum recorded cell viability for normal cell lines was 84.78% at 20 mg/mL concentration. In contrast cell viability of cancer cell lines in contact with casein coated MNPs core‐shell structure except for one sample remained below 85%. By introduction of and alternating magnetic field, cell viability of samples with lower MNP concentration dropped by 20% to 30% while this drop for samples with higher concentration was 10% to 20%. Furthermore, results of in vivo trials show that just 1 week of hyperthermia treatment with casein coated MNPs core‐shell structure can reduce the tumor size of the mice by 33%. Real‐time polymerase chain reaction results further confirmed the effectiveness of this method. Moreover, findings of this study suggest that lower injection speed can improve NPs distribution and treatment effect. Results of this study suggest that core‐shell structure can positively affect the tumor growth and the combination of good biocompatibility, innate hostility toward cancer cells and good heating power makes them a good candidate for hyperthermia cancer therapy applications.
- 26 February 2020
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 31 (7) , 1544-1552
Biocompatibility and hyperthermia cancer therapy of casein‐coated iron oxide nanoparticles in mice
Magnetic nanoparticles (MNPs) can be used as heat generation source in cancer hyperthermia therapy. While iron oxide nanoparticles (NPs) are the most popular choice for magnetic hyperthermia, adding a surface enhancement can improve its performance. Furthermore, for MNPs to be used in biomedical application their cytotoxicity needs to be evaluated. In this study biocompatibility and also in vivo performance of casein‐coated MNPs were assessed. Cell viability of normal cell lines in all of tests remained above 95% for 0.5 and 1 mg/mL concentration and even the minimum recorded cell viability for normal cell lines was 84.78% at 20 mg/mL concentration. In contrast cell viability of cancer cell lines in contact with casein coated MNPs core‐shell structure except for one sample remained below 85%. By introduction of and alternating magnetic field, cell viability of samples with lower MNP concentration dropped by 20% to 30% while this drop for samples with higher concentration was 10% to 20%. Furthermore, results of in vivo trials show that just 1 week of hyperthermia treatment with casein coated MNPs core‐shell structure can reduce the tumor size of the mice by 33%. Real‐time polymerase chain reaction results further confirmed the effectiveness of this method. Moreover, findings of this study suggest that lower injection speed can improve NPs distribution and treatment effect. Results of this study suggest that core‐shell structure can positively affect the tumor growth and the combination of good biocompatibility, innate hostility toward cancer cells and good heating power makes them a good candidate for hyperthermia cancer therapy applications.
- 11 September 2019
- Published by Springer Nature in Journal of Materials Science
- Vol. 55 (1) , 319-336
A new generation of star polymer: magnetic aromatic polyamides with unique microscopic flower morphology and in vitro hyperthermia of cancer therapy
- 11 September 2019
- Published by Springer Nature in Journal of Materials Science
- Vol. 55 (1) , 319-336
A new generation of star polymer: magnetic aromatic polyamides with unique microscopic flower morphology and in vitro hyperthermia of cancer therapy
- 1 June 2019
- Published by World Scientific Pub Co Pte Ltd in SPIN
- Vol. 09 (02)
Casein-Coated Iron Oxide Nanoparticles for in vitro Hyperthermia for Cancer Therapy
- 1 June 2019
- Published by World Scientific Pub Co Pte Ltd in SPIN
- Vol. 09 (02)
Casein-Coated Iron Oxide Nanoparticles for in vitro Hyperthermia for Cancer Therapy